Embecta Corp. (EMBC)
10.75
+0.22
(+2.09%)
USD |
NASDAQ |
Feb 20, 10:33
Embecta EPS Diluted (Quarterly) : 0.7438 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.944 |
| Curis, Inc. | -0.4929 |
| LadRx Corp. | -1.453 |
| Plus Therapeutics, Inc. | -0.0412 |
| Windtree Therapeutics, Inc. | -1.085 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 44.10M |
| Revenue (Quarterly) | 261.20M |
| Total Expenses (Quarterly) | 217.10M |
| Enterprise Value | 1.829B |
| Gross Profit Margin (Quarterly) | 67.23% |
| Profit Margin (Quarterly) | 16.88% |
| Earnings Yield | 22.06% |
| Operating Earnings Yield | 54.75% |
| Normalized Earnings Yield | 28.64 |